Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab and Dendritic Cells in Eosinophilic Asthma
NCT03652376Phase 4Unknown
- Sponsor
- Universität Rostock
- Start
- Sep 2018
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of benralizumab in eosinophilic asthma (EA), sponsored by Universität Rostock. Status: unknown.
02
Drugs
benralizumab
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on NCT03652376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03652376.